Drug profile · INN
adsorbed cell culture-derived influenza vaccine (h5n1)
ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO"
- Patents linked
- 0
- News articles
- 0
Quick answer
adsorbed cell culture-derived influenza vaccine (h5n1) (ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO") is an FDA-listed pharmaceutical active ingredient.
Key facts
Frequently asked questions
What is adsorbed cell culture-derived influenza vaccine (h5n1)?
adsorbed cell culture-derived influenza vaccine (h5n1) (ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO") is an FDA-listed pharmaceutical active ingredient.
What is the brand name for adsorbed cell culture-derived influenza vaccine (h5n1)?
ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO" is a marketed brand name for adsorbed cell culture-derived influenza vaccine (h5n1). Check FDA Drugs@FDA for the current US label holder and prescribing information.